Clinical trial Recruiting at 1 site Interventional Ages 22 to 100

Embolization treatment for heel pain from plantar fasciitis

Official title: Embolization for the Treatment of Heel Pain Secondary to Plantar Fasciitis

Run by IR Centers · NCT06805942 · Data updated 2026-11-12

This study is testing a new treatment using a special substance to see if it can help people with heel pain from plantar fasciitis feel better and improve their foot function.

More Plantar Fasciitis of Both Feet trials

Quick facts

Study typeInterventional
Ages22 Years to 100 Years
SexAll
Enrollment10 (estimated)
SponsorIR Centers
Academic / other
Locations1 site (Falls Church, Virginia)
StatusRecruiting
StartedFebruary 15, 2025
Main results expectedSeptember 30, 2025
Study endsSeptember 30, 2025
Registry record updatedFebruary 3, 2025
Trial IDNCT06805942 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 22 years or older with a diagnosis of plantar fasciitis who have not responded to at least six weeks of conservative therapies.

Probably not a fit

Patients with heel pain due to stress fractures, nerve entrapment, inflammatory conditions, or those who have had recent corticosteroid injections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the safety and feasibility of using Lipiodol, an investigational embolic agent, for treating heel pain caused by plantar fasciitis. Participants will undergo a minimally invasive procedure known as plantar fascia embolization (PFE) aimed at reducing inflammation and pain in the affected area. The study will assess changes in pain levels, foot function, and any potential side effects over a six-month follow-up period.

Why it matters

Potential benefit: If successful, this treatment could significantly reduce heel pain and improve foot function for patients suffering from plantar fasciitis.

How similar studies have gone: While the use of embolization for plantar fasciitis is a novel approach, similar studies in other conditions have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:Participants aged 22 years or older. Diagnosed with plantar fasciitis by an orthopedic or podiatry surgeon.

Ultrasound evaluation showing:

Increased plantar fascia thickness \> 4 mm. Hyperemia in the plantar fascia near its proximal insertion or perifascial soft tissue.

Self-reported pain of at least 5/10 on the Visual Analog Scale (VAS). Negative X-ray for acute fractures. Refractory to at least 6 weeks of conservative therapies. Able to provide written informed consent. -

Exclusion Criteria:Heel pain caused by stress fractures, nerve entrapment, or inflammatory conditions such as arthritis, gout, or bursitis.

Corticosteroid injection in the plantar fascia within 90 days prior to embolization.

Prior surgical repair or plantar fascia rupture. Severe allergy to Lipiodol or iodinated contrast media. Diagnosis of peripheral arterial disease affecting the lower extremities. Active workers' compensation claim for plantar fasciitis. Pregnancy or breastfeeding. Type 1 Diabetes Mellitus or significant renal dysfunction (GFR \< 45 or serum creatinine \> 2.0 mg/dL).

Sensory or motor neuropathy of the feet. Active skin wounds on the plantar surface of the affected foot.

\-

Where it's running

  • IR Centers
    Falls Church, Virginia, United States
    Recruiting

Study contacts

  • Principal investigator: Sandeep Bagla, MD — IR Centers
  • Study coordinator: Sindhuja Kommidi Clinical Research Coordinator, MS
  • Email: sindhu@ircenters.com
  • Phone: 7327831259

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.